Related Experiment Video
Updated: Nov 26, 2025
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
4.0K
Hypertrophic Cardiomyopathy: A Review
Silméia Garcia Zanati Bazan1, Gilberto Ornellas de Oliveira1, Caroline Ferreira da Silva Mazeto Pupo da Silveira1
1Universidade Estadual Paulista Júlio de Mesquita Filho - Faculdade de Medicina de Botucatu - UNESP, Botucatu, SP - Brasil.
Arquivos Brasileiros De Cardiologia
|December 9, 2020
Summary
Hypertrophic cardiomyopathy (HCM) is a common genetic heart disease characterized by left ventricular hypertrophy. This review covers diagnostic advancements and prognostic assessments for HCM, aiding in clinical severity stratification.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- Hypertrophic cardiomyopathy (HCM) is the most prevalent genetic heart disease.
- It is defined by left ventricular hypertrophy unexplained by other cardiac or systemic conditions.
- HCM presents a spectrum from asymptomatic cases to severe heart failure and sudden cardiac death.
Purpose of the Study:
- To review contemporary advancements in diagnosing and assessing hypertrophic cardiomyopathy.
- To discuss the role of high-resolution imaging and clinical scores in prognostic evaluation.
- To provide an updated overview of hypertrophic cardiomyopathy, including classic aspects and clinical severity stratification.
Main Methods:
- Review of current literature on hypertrophic cardiomyopathy.
- Analysis of contemporary high-resolution imaging techniques.
- Evaluation of updated clinical scoring systems for prognostic assessment.
Main Results:
- High-resolution imaging and refined clinical scores improve prognostic accuracy in HCM.
- These tools aid in stratifying patients based on clinical severity.
- A comprehensive understanding of HCM requires integrating advanced diagnostics with classic disease knowledge.
Conclusions:
- Advanced imaging and clinical scores are crucial for managing hypertrophic cardiomyopathy.
- Accurate prognostic assessment allows for better patient stratification and care.
- This review synthesizes current knowledge for improved understanding and management of HCM.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
176
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
176
01:29Cardiomyopathy V: Interprofessional Care
133
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
133
01:25Cardiomyopathy I: Introduction and Classification
288
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
288
01:30Cardiomyopathy II: Dilated Cardiomyopathy
197
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
197
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
253
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
253
01:29Heart Failure II: Pathophysiology
301
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
301